140 results
6-K
EX-99.1
ALVO
Alvotech
22 May 24
Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
6:30am
as specifically set forth therein, Alvotech disclaims responsibility for the content of periodic filings, disclosures and other reports made available
6-K
EX-99.1
ALVO
Alvotech
21 May 24
Current report (foreign)
9:00am
) and territories. Except as specifically set forth therein, Alvotech disclaims responsibility for the content of periodic filings, disclosures
6-K
EX-99.1
ALVO
Alvotech
21 May 24
Current report (foreign)
8:41am
as specifically set forth therein, Alvotech disclaims responsibility for the content of periodic filings, disclosures and other reports made
6-K
EX-99.1
ALVO
Alvotech
30 Apr 24
Current report (foreign)
8:00am
forth therein, Alvotech disclaims responsibility for the content of periodic filings, disclosures and other reports made available by its partners
6-K
EX-99.1
ALVO
Alvotech
25 Apr 24
Current report (foreign)
12:36pm
disclaims responsibility for the content of periodic filings, disclosures and other reports made available by its partners. For more information, please
6-K
EX-99.1
oi8sb82r
19 Apr 24
Current report (foreign)
8:05am
6-K
EX-99.1
kqxnakr
16 Apr 24
Current report (foreign)
6:30pm
6-K
EX-99.1
t0vf8kskteqc
22 Mar 24
Alvotech Announces Increase in Number of Own Shares
4:15pm
6-K
EX-99.2
f5oga6dzlfrxtcl8a1
20 Mar 24
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
4:30pm
6-K
EX-99.1
dn638
20 Mar 24
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
4:30pm
6-K
EX-99.1
votar
1 Mar 24
Alvotech Appoints Interim Chief Quality Officer
12:16pm
6-K
EX-99.1
5tfhhbsh cgexzjd6h
26 Feb 24
Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share
7:00am
6-K
EX-99.1
p5vzq979
23 Feb 24
Current report (foreign)
8:39pm
6-K
EX-99.1
89ex6q1v
15 Feb 24
Current report (foreign)
4:00pm
6-K
EX-99.1
gxvyv1zgdclxefnxnua
29 Jan 24
Current report (foreign)
7:00am
6-K
EX-99.1
ce4lu lah3uy6909upcn
19 Jan 24
Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04
4:00pm
6-K
EX-99.1
0wdtrm
10 Jan 24
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
7:00am
6-K
EX-99.1
lxchs 4ta1vfubi
3 Jan 24
Current report (foreign)
2:28pm